Skip to content
DraconiticResearch
Search Sources API
210,418 studies31 sourcesUpdated 7 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. Precision Oncology: Cancer Specialists’ Perspectives on Molecular Profiling, Targeted Therapy, and Barriers to Access
    Pushpita Roy, Dipaloke Banik, Syed Md. Asadul Hoque +1
    Journal of Clinical Medicine ResearchPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  2. Lipid Metabolic Reprogramming and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights From Lipidomics
    Revathi Valliyodu, Diya Maria Siril, Harsha Sanil +9
    Cell biochemistry and functionPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. Development and Psychometric Assessment of a Measurement Instrument for Functioning and Function-Affecting Factors in Women With Breast Cancer: A Rasch Analysis Approach.
    Farkhondeh Jamshidihosseinabadi, Maryam Farzad, Enayatollah Bakhshi +7
    Journal of evaluation in clinical practicePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  4. Consensus and controversy of liquid biopsy using circulating tumour DNA (ctDNA) for molecular residual disease detection in colorectal cancer
    Alicia Yioli Lefas, Ian Chau
    The Lancet Regional Health. Western PacificPeer-reviewedCC BY-NCFull textOncologyDOAJEurope PMCPMC
  5. Distant lymph nodes compensate for resected tumor-draining lymph nodes during cancer immunotherapy
    Lutz Menzel, Hengbo Zhou, James W. Baish +17
    ImmunityPeer-reviewedCC BY-NC-ND13 citedOncologyOpenAlex
  6. CBFA2T3-GLIS2 establishes transcriptionally permissive enhancer hypermethylation associated with venetoclax response in pediatric AML
    S. Roy Choudhury, A. Chavan, R. Ries +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  7. RORγ Inverse Agonism Redirects Tumour-Conditioned Emergency Myelopoiesis and Attenuates Established Tumour Progression
    I. Dhoparee-Doomah, K. Ma, A. Brassard +15
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  8. Dynamic Schlafen 11 (SLFN11) expression revealed by single-cell RNA sequencing of clonal human cancer cells
    D. Taniyama, Y. Inoue, F. Elloumi +8
    bioRxivPreprintCC0Full textOncologybioRxiv
  9. Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer
    N. D. Ebelt, S. Loganathan, L. C. Avsharian +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  10. PWK genetic background reprograms heterochromatin and malignant epithelial states in Neu-driven mammary tumors
    R. Geng, R. R. Ray, J. B. Jacob +1
    bioRxivPreprintCC BYFull textOncologybioRxiv
  11. Metabolic rewiring induces a viral mimicry-mediated quiescence in glioblastoma
    C. Chesnelong, K. Desai, C. S. Charton +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  12. Mechanistic Decoding of Pharmacodynamic Intratumoral Heterogeneity: A Pan-Cancer Regulatory Framework
    Z. Ren, Y. Ren, Z. Li +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  13. Acute Metabolic Switch by High-Dose Dehydroascorbic Acid: Rapid TCA Cycle Depletion and Early Signature of Methionine Trap within 1 Hour in KRAS-Mutant Cells
    N. Hatakeyama, T. Miyazawa, M. Toda +1
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  14. KRASG12C Inhibition Remodels the Non-Small Cell Lung Cancer Surfaceome to Uncover Targetable Vulnerabilities
    A. Padhye, K. Kang, F. Y. Kong +14
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  15. Tumor stiffness creates a ferroptotic Achilles heel through YAP SKP2 signaling
    E. Villares, N. Taber, S.-C. Wu +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  16. TangentXY: Improved copy-number estimation of sex chromosomes reveals features associated with aneuploidies in chromosomes X and Y across cancers
    K. Enomoto, S. Sarmashghi, S. Misek +10
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  17. A ncBAF to cBAF Switch Regulates Human Hematopoietic Progenitor Myeloid Differentiation
    E. R. Adelman, A. A. Adele, C. Ricardo Gutierrez Silva +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  18. KRAS inhibition drives adaptive surfaceome remodeling and reveals ALPP/ALPPL2 as a targetable vulnerability in pancreatic cancer
    J. M. DeLiberty, F. Y. Kong, Q. Yu +25
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  19. The Role of Antinuclear Antibody in Predicting the Efficacy and Immune-Related Adverse Events of Immunochemotherapy in Esophageal Squamous Cell Carcinoma: A Real-World Analysis.
    Ansu Li, Yue Tao, Kongcheng Wang +4
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  20. Up-Front Immune Checkpoint Inhibitors in Patients with Multiple Synchronous Primary Tumors, Including dMMR/MSI-H Gastrointestinal Malignancies: A Case Series and Review of the Literature.
    Angela Damato, Martina Rotolo, Nicoletta Sparacino +5
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  21. Urinary Biomarkers in Cancer: A Scoping Review
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  22. Identification of Survival-Associated miRNA Signatures in Glioblastoma Using Next-Generation Sequencing
    Andrea Bakó, Bernadett Torner, Dóra Géczi +4
    Non-coding RNAPeer-reviewedCC BYFull textOncologyEurope PMC
  23. Tissue-Specific miRNA Responses to Tick-Borne Encephalitis Virus Strains in Mice
    Elena V. Mikheeva, Galina S. Chicherina, Kseniya S. Aulova +2
    Non-coding RNAPeer-reviewedCC BYFull textOncologyEurope PMC
  24. Myeloid-Adaptive Response to Atezolizumab (MARTA): A Two-Gene CXCL13–CXCL8 Transcriptomic Biomarker Across Renal Cell and Urothelial Carcinoma
    Mario Uccello
    Current issues in molecular biologyPeer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  25. Peripheral and selective venous liquid biopsy profiling in localized prostate cancer: A pilot feasibility study.
    Riccardo Ricotta, Giuseppe Trifirò, Elena Maria Andreolli +3
    The journal of liquid biopsyPeer-reviewedCC BYFull textOncologyEurope PMC